FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108653569> ?p ?o ?g. }

• W2108653569 endingPage "e8" @default.
• W2108653569 startingPage "e8" @default.
• W2108653569 abstract "Infants with perinatally acquired human immunodeficiency virus type 1 (HIV-1) infection have widely variable courses. Previous studies showed that a number of maternal and infant factors, when analyzed separately, are associated with infant HIV-1 disease progression. In this study, clincal, virologic, and immunologic characteristics in the mothers and infants were examined together to determine the predictors of disease progression by 18 months of age and the associations with rapid progression during the first 6 months of life.One hundred twenty-two HIV-1-infected women whose infants were HIV-1 infected were identified from the Women and Infants Transmission Study (WITS) cohort. WITS is a longitudinal natural history study of perinatal HIV-1 infection carried out in 6 sites in the continental United States and in Puerto Rico. The women were enrolled during pregnancy and their infants were enrolled at the time of delivery and followed prospectively by a standardized protocol. Virologic and immunologic studies were performed in laboratories certified by National Institutes of Health-sponsored quality assurance programs. Maternal factors in pregnancy were used as potential predictors of infant disease progression (progression to Centers for Disease Control and Prevention [CDC] Clinical Class C disease or death by 18 months of age) or as correlates of progression at <6 months of age. Infant factors defined during the first 6 months of life were used as potential predictors of progression during 6 to 18 months of age and as correlates of progression at <6 months of age.Progression by 18 months of age occurred in 32% of infants and by 6 months of age in 15%. Maternal characteristics that, by univariate analysis, were significant predictors of infant disease progression by 18 months of age were elevated viral load, depressed CD4(+)%, and depressed vitamin A. CD8(+)%, CD8(+) activation markers, zidovudine (ZDV) use, hard drug use, and gestational age at delivery were not. When examined in a combined multivariate analysis of maternal characteristics, only vitamin A concentration independently predicted infant progression. Infant characteristics during the first 6 months of life that, by univariate analysis, were associated with disease progression included elevated mean viral load at 1 to 6 months of age, depressed CD4(+)%, CDC Clinical Disease Category B, and growth delay. Early HIV-1 culture positivity (<48 hours), CD8(+)%, CD8(+) activation markers, and ZDV use during the first month of life did not predict progression. Multivariate analysis of infant characteristics showed that the only independent predictors were progression to CDC Category B by 6 months of age (odds ratio [OR], 5.80) and mean viral load from 1 to 6 months of age (OR, 1.99). The final combined maternal and infant analysis included the significant maternal and infant characteristics in a multivariate analysis. It showed that factors independently predicting infant progression by 18 months of age were progression to CDC Category B by 6 months of age (OR, 5.80) and elevated mean HIV-1 RNA copy number at 1 to 6 months of age (OR, 1.99). The characteristics associated with rapid progression to CDC Category C disease or death by 6 months of age were also examined. The only maternal characteristic associated with progression by 6 months in multivariate analysis was low maternal CD4(+)%. The infant characteristics associated with progression by 6 months of age in multivariate analysis were depressed mean CD4(+)% from birth through 2 months and the presence of lymphadenopathy, hepatomegaly, or splenomegaly by 3 months. Infant ZDV use was not assocciated with rapid progression.The strongest predictors of progression by 18 months are the presence of moderate clinical symptoms and elevated RNA copy number in the infants in the first 6 months of life. In contrast, progression by 6 months is associated with maternal and infant immun" @default.
• W2108653569 created "2016-06-24" @default.
• W2108653569 creator A5004315082 @default.
• W2108653569 creator A5007707615 @default.
• W2108653569 creator A5007797529 @default.
• W2108653569 creator A5023876677 @default.
• W2108653569 creator A5032224704 @default.
• W2108653569 creator A5033295739 @default.
• W2108653569 creator A5035703573 @default.
• W2108653569 creator A5045210930 @default.
• W2108653569 creator A5055820796 @default.
• W2108653569 date "2000-01-01" @default.
• W2108653569 modified "2023-10-15" @default.
• W2108653569 title "Maternal and Infant Factors Predicting Disease Progression in Human Immunodeficiency Virus Type 1-Infected Infants" @default.
• W2108653569 cites W1784147363 @default.
• W2108653569 cites W1894438159 @default.
• W2108653569 cites W1968100755 @default.
• W2108653569 cites W1969756606 @default.
• W2108653569 cites W1976290918 @default.
• W2108653569 cites W1979215465 @default.
• W2108653569 cites W2002901217 @default.
• W2108653569 cites W2034160312 @default.
• W2108653569 cites W2048099499 @default.
• W2108653569 cites W2050240695 @default.
• W2108653569 cites W2069054708 @default.
• W2108653569 cites W2074512582 @default.
• W2108653569 cites W2086566113 @default.
• W2108653569 cites W2104476042 @default.
• W2108653569 cites W2113868586 @default.
• W2108653569 cites W2153736652 @default.
• W2108653569 cites W2161202915 @default.
• W2108653569 cites W2166229810 @default.
• W2108653569 cites W2169273126 @default.
• W2108653569 cites W2312499014 @default.
• W2108653569 cites W2313922401 @default.
• W2108653569 cites W2315236452 @default.
• W2108653569 cites W2316970929 @default.
• W2108653569 cites W2321822034 @default.
• W2108653569 cites W2329170144 @default.
• W2108653569 cites W2339423424 @default.
• W2108653569 cites W2421033132 @default.
• W2108653569 cites W2601427756 @default.
• W2108653569 cites W4256006039 @default.
• W2108653569 doi "https://doi.org/10.1542/peds.105.1.e8" @default.
• W2108653569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10617745" @default.
• W2108653569 hasPublicationYear "2000" @default.
• W2108653569 type Work @default.
• W2108653569 sameAs 2108653569 @default.
• W2108653569 citedByCount "86" @default.
• W2108653569 countsByYear W21086535692012 @default.
• W2108653569 countsByYear W21086535692013 @default.
• W2108653569 countsByYear W21086535692015 @default.
• W2108653569 countsByYear W21086535692016 @default.
• W2108653569 countsByYear W21086535692017 @default.
• W2108653569 countsByYear W21086535692018 @default.
• W2108653569 countsByYear W21086535692019 @default.
• W2108653569 countsByYear W21086535692020 @default.
• W2108653569 countsByYear W21086535692021 @default.
• W2108653569 countsByYear W21086535692023 @default.
• W2108653569 crossrefType "journal-article" @default.
• W2108653569 hasAuthorship W2108653569A5004315082 @default.
• W2108653569 hasAuthorship W2108653569A5007707615 @default.
• W2108653569 hasAuthorship W2108653569A5007797529 @default.
• W2108653569 hasAuthorship W2108653569A5023876677 @default.
• W2108653569 hasAuthorship W2108653569A5032224704 @default.
• W2108653569 hasAuthorship W2108653569A5033295739 @default.
• W2108653569 hasAuthorship W2108653569A5035703573 @default.
• W2108653569 hasAuthorship W2108653569A5045210930 @default.
• W2108653569 hasAuthorship W2108653569A5055820796 @default.
• W2108653569 hasConcept C126322002 @default.
• W2108653569 hasConcept C163276114 @default.
• W2108653569 hasConcept C187212893 @default.
• W2108653569 hasConcept C188816634 @default.
• W2108653569 hasConcept C201903717 @default.
• W2108653569 hasConcept C203014093 @default.
• W2108653569 hasConcept C2779134260 @default.
• W2108653569 hasConcept C2779234561 @default.
• W2108653569 hasConcept C54355233 @default.
• W2108653569 hasConcept C71924100 @default.
• W2108653569 hasConcept C72563966 @default.
• W2108653569 hasConcept C86803240 @default.
• W2108653569 hasConceptScore W2108653569C126322002 @default.
• W2108653569 hasConceptScore W2108653569C163276114 @default.
• W2108653569 hasConceptScore W2108653569C187212893 @default.
• W2108653569 hasConceptScore W2108653569C188816634 @default.
• W2108653569 hasConceptScore W2108653569C201903717 @default.
• W2108653569 hasConceptScore W2108653569C203014093 @default.
• W2108653569 hasConceptScore W2108653569C2779134260 @default.
• W2108653569 hasConceptScore W2108653569C2779234561 @default.
• W2108653569 hasConceptScore W2108653569C54355233 @default.
• W2108653569 hasConceptScore W2108653569C71924100 @default.
• W2108653569 hasConceptScore W2108653569C72563966 @default.
• W2108653569 hasConceptScore W2108653569C86803240 @default.
• W2108653569 hasIssue "1" @default.
• W2108653569 hasLocation W21086535691 @default.
• W2108653569 hasLocation W21086535692 @default.
• W2108653569 hasOpenAccess W2108653569 @default.
• W2108653569 hasPrimaryLocation W21086535691 @default.

• next